News & Media

The TechVision Fonds brings in new capital in PL BioScience We are proud to announce that with the support of SilverSky LifeSciences we successfully managed to convince the TechVision Fonds to invest in our start-up business. The TechVision Fonds, managed by the S-UBG group, supports innovative start-up

READ MORE

New Zealand plans to slaughter 150,000 cows as it tries to eradicate a strain of disease-causing Mycoplasma bovis bacteria. The bacteria was found for the first time in New Zealand in 2017 and can cause cows to develop mastitis, pneumonia, arthritis and other diseases. The impacts on the use and

READ MORE

Article in the Memebers Information Booklet 'Doctors Against Animal Experiments Germany' (Issue 3/2017) (Article only available in German) Textauszüge:   "Der wichtigste Grund, weshalb auf den Gebrauch von fetalem Kälberserum verzichtet werden sollte, ist, dass die Gewinnung mit erheblichem Leid und dem Tod von Millionen Kälberfeten einhergeht."   "Um das millionenfache

READ MORE

Interview with our colleague Ute Steinbusch in the issue 3/2016 of the magazine 'Laborjournal' (Article only available in German) Textauszug:   "Die Zahl serumfreier Alternativen zum FBS steigt. Ein Start-up aus Aachen beispielsweise bietet humanes Blutplättchenlysat (hPL) als Wachstumsmedium an - auf Wunsch sogar dreidimensional. Ein Gespräch über Zweitverwertung und

READ MORE
Additionally, paste this code immediately after the opening tag:
Any questions?
close slider

Any questions?

Please contact us:

support@pl-bioscience.com

+49 (0) 241 95719-100